This latest research on non-dystrophic myotonia offers promising results for those affected by the condition. Published in ...

Buprenorphine is relatively safe and reduces the risk of opioid death by 38% compared with those not receiving medication.

The FDA approved Cobenfy, a new drug for people with schizophrenia that comes with fewer side effects than other ...

On Thursday, the U.S. Food and Drug Administration (FDA) approved the drug Cobenfy which targets schizophrenia in a new way.

It's been one month since Oregon's new drug possession charge took affect and most counties have been operating a deflection ...

Available antipsychotic treatments work by blocking dopamine receptors. The new drug, Cobenfy, takes a different approach.

The U.S. Food and Drug Administration (FDA) on Thursday approved Bristol Myers Squibb’s (BMY) highly anticipated ...

The need for more support and funding for drug and alcohol treatment in Ballarat has been highlighted again, with a new ...

Health department data show a 7% decrease from 2022 to 2023, reflecting national trends. But racial disparities remain high ...

Cobenfy gives patients an alternative to drugs with troublesome side effects.

Gilead Sciences said on Wednesday it has granted royalty-free licenses to six generic drug manufacturers to make and sell ...

The twice-daily pill, Cobenfy, is a badly needed new treatment option for the nearly 3 million adults in the U.S. living with ...